June 4, 2019

Cancer Vaccine Shows Potential against iNHL in Early Results

News

A new cancer vaccine still in clinical testing showed potential for driving disease remission in patients with advanced indolent non-Hodgkin’s lymphoma (iNHL) and may help restore efficacy of immunotherapies, including ... Read more

November 27, 2018

Opdivo Halts Hodgkin’s Progression in Those Who Earlier Had Achieved Remission, Study Shows

News

Re-treatment with Opdivo (nivolumab) may be a safe and effective option to halt disease progression in patients with classical Hodgkin’s lymphoma (cHL) who previously achieved disease remission with the treatment, a ... Read more